Lates News

In the morning of August 7th, Bo'an Biotechnology announced on the Hong Kong Stock Exchange that on August 6th, 2025, the company and the placing agents entered into a placing agreement. The total number of placing shares to be sold in the placing is 48 million shares, equivalent to approximately 8.36% of the total number of shares issued as of the date of this announcement. The placing price is HK$16.42 per share, representing a discount of approximately 8.78% to the closing market price on the last trading day on the Stock Exchange. The net proceeds expected to be raised from the placing are approximately HK$780 million, with around 50% to be used for research and development, clinical trials, regulatory filings, and manufacturing of innovative candidate products; around 20% for the commercialization of existing and upcoming products; and around 30% for supplementing the company's working capital and general corporate purposes.